Furthermore, compared to the Ex-HCT116 group, knockdown of circPACRGL remarkably decreased the CRC cell proliferation, while this inhibition was diminished after miR-142-3p/miR-506-3p inhibitor treatment or TGF-β1 overexpression (Fig. 5a). The gene discussed is TGFB1; the disease is colorectal carcinoma.